Logo image of DATS

DATCHAT INC (DATS) Stock Fundamental Analysis

NASDAQ:DATS - Nasdaq - US23816M2061 - Common Stock - Currency: USD

3.23  +0.33 (+11.38%)

After market: 3.2 -0.03 (-0.93%)

Fundamental Rating

2

Taking everything into account, DATS scores 2 out of 10 in our fundamental rating. DATS was compared to 284 industry peers in the Software industry. While DATS has a great health rating, there are worries on its profitability. DATS does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year DATS has reported negative net income.
DATS had a negative operating cash flow in the past year.
In the past 5 years DATS always reported negative net income.
DATS had a negative operating cash flow in each of the past 5 years.
DATS Yearly Net Income VS EBIT VS OCF VS FCFDATS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -2M -4M -6M -8M -10M

1.2 Ratios

DATS has a worse Return On Assets (-53.77%) than 84.51% of its industry peers.
DATS has a worse Return On Equity (-44.49%) than 66.20% of its industry peers.
Industry RankSector Rank
ROA -53.77%
ROE -44.49%
ROIC N/A
ROA(3y)-100.23%
ROA(5y)-97.03%
ROE(3y)-98.69%
ROE(5y)-103.79%
ROIC(3y)N/A
ROIC(5y)N/A
DATS Yearly ROA, ROE, ROICDATS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for DATS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
DATS Yearly Profit, Operating, Gross MarginsDATS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 -200K -400K -600K -800K -1M

More info and screens

7

2. Health

2.1 Basic Checks

DATS does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for DATS has been increased compared to 1 year ago.
DATS has more shares outstanding than it did 5 years ago.
DATS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
DATS Yearly Shares OutstandingDATS Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 1M 2M 3M
DATS Yearly Total Debt VS Total AssetsDATS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

DATS has an Altman-Z score of -14.12. This is a bad value and indicates that DATS is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of DATS (-14.12) is worse than 89.79% of its industry peers.
There is no outstanding debt for DATS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -14.12
ROIC/WACCN/A
WACC11.24%
DATS Yearly LT Debt VS Equity VS FCFDATS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 5M -5M 10M 15M 20M

2.3 Liquidity

A Current Ratio of 10.30 indicates that DATS has no problem at all paying its short term obligations.
DATS has a better Current ratio (10.30) than 94.01% of its industry peers.
A Quick Ratio of 10.30 indicates that DATS has no problem at all paying its short term obligations.
DATS has a Quick ratio of 10.30. This is amongst the best in the industry. DATS outperforms 94.01% of its industry peers.
Industry RankSector Rank
Current Ratio 10.3
Quick Ratio 10.3
DATS Yearly Current Assets VS Current LiabilitesDATS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

0

3. Growth

3.1 Past

DATS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 58.54%, which is quite impressive.
Looking at the last year, DATS shows a very negative growth in Revenue. The Revenue has decreased by -20.00% in the last year.
EPS 1Y (TTM)58.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%11.15%
Revenue 1Y (TTM)-20%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%0%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
DATS Yearly Revenue VS EstimatesDATS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 10K 20K 30K 40K

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

DATS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DATS Price Earnings VS Forward Price EarningsDATS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DATS Per share dataDATS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for DATS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DATCHAT INC

NASDAQ:DATS (6/10/2025, 8:00:01 PM)

After market: 3.2 -0.03 (-0.93%)

3.23

+0.33 (+11.38%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-25 2022-11-25/bmo
Earnings (Next)N/A N/A
Inst Owners4.08%
Inst Owner Change51.48%
Ins Owners4.16%
Ins Owner Change0%
Market Cap13.60M
Analysts0
Price TargetN/A
Short Float %6.79%
Short Ratio0.08
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 33995.75
P/FCF N/A
P/OCF N/A
P/B 1.32
P/tB 1.48
EV/EBITDA N/A
EPS(TTM)-1.39
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.04
FCFYN/A
OCF(TTM)-1.03
OCFYN/A
SpS0
BVpS2.44
TBVpS2.18
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -53.77%
ROE -44.49%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-100.23%
ROA(5y)-97.03%
ROE(3y)-98.69%
ROE(5y)-103.79%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 10.3
Quick Ratio 10.3
Altman-Z -14.12
F-Score4
WACC11.24%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)58.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%11.15%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-20%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%0%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y33.36%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y33.5%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y36.43%
OCF growth 3YN/A
OCF growth 5YN/A